Day 1: November 7, 2023
|
11:00 – 11:10 am |
Introduction to the Mini-Convention
Nora D. Volkow, M.D., Director, NIDA
George Koob, Ph.D., Director, NIAAA
|
| 11:10 am – 12:10 pm |
Jacob P. Waletzky Memorial Award Lecture
|
| 12:10 – 12:20 pm |
Break
|
| 12:20 – 1:50 pm |
Scientific Session I. Using Neuroscience to Inform Prevention Interventions for Substance Use
Co-Chairs:
Alexa Romberg, Ph.D., NIDA
Vani Pariyadath, Ph.D., NIDA
Speakers:
Diana Fishbein, Ph.D., University of North Carolina
Title: A Translational Neuroscience Framework for Personalizing and Optimizing Preventive Intervention Models
Catherine Hartley, Ph.D., New York University
Title: Learning computations as potential neurocognitive mechanisms underlying developmental vulnerability to addiction
Catalina Lopez-Quintero, M.D., Ph.D., University of Florida
Title: Targets for intervention to prevent problematic cannabis use: Exploring the complex relationships between socio-cultural, neurocognitive, and behavioral factors
Christopher N. Cascio, Ph.D., University of Wisconsin - Madison
Title: Interventions targeting neural correlates associated with persuasion and social influence
|
| 1:50 – 3:20 pm |
Scientific Session II. Glial Cells and Neuroimmune Mechanisms in Substance Use Disorders
Co-Chairs:
Shang-Yi Anne Tsai, Ph.D., NIDA
Sam Ananthan, Ph.D., NIDA
Speakers:
Marie-Ève Tremblay, Ph.D., University of Victoria
Title: Effects of Cannabis and Psychedelics on Microglia
Shashank M. Dravid, Ph.D., Creighton University School of Medicine
Title: Astrocytic NMDA receptors in the regulation of synaptic function and addiction behavior
Anna Kruyer, Ph.D., University of Cincinnati
Title: Astrocyte Regulation of Neural Circuit Activity During Opioid Relapse
|
Day 2: November 8, 2023
|
11:00 – 11:15 am
|
Day 2 Opening Remarks
Rita Valentino, Ph.D., DNB Director, NIDA
Antonio Noronha, Ph.D., DNB Director, NIAAA
|
| 11:15 am – 1:00 pm |
Joint NIDAA-NIAAA Early Career Investigator Showcase
Awardees:
Luana Carvalho, Ph.D. Virginia Commonwealth University
Title: Conserved role for PCBP1 in altered RNA splicing in the hippocampus after chronic alcohol exposure
Khalin Nisbett, M.S. National Institute on Drug Abuse
Title: Opioid antagonism modulates oxytocin-induces anxiolytic-like behavior: Implications for Treatment of Substance Use Disorders
Meghan Flanigan, Ph.D. University of North Carolina School of Medicine
Title: Lateral Habenula neurons expressing the serotonin receptor 5HT2c drive sex-specific social and arousal disturbances induced by binge alcohol consumption
Hojin Shin, Ph.D. Mayo Clinic
Title: Investigating dopaminergic/serotonergic mechanism during synthetic opioid use
Valentina Vozella, Ph.D. The Scripps Research Institute
Title: Adolescent Social Isolation Increases Alcohol Drinking and Anxiety-Like Behavior: Role for Disrupted Endocannabinoid Signaling in the Central Amygdala.
Arlene Martínez-Rivera, Ph.D. Weill Cornell Medicine
Title: The inhibition of MAG Lipase reduces opioid reward via VTA CB1 receptors without altering analgesia
|
| 1:00 – 1:20 pm |
Break (Photo time for ECIS awardees and IC directors)
|
| 1:20 – 2:50 pm |
Scientific Session III. Alcohol and Substance Use Disorders and the Glymphatic System
Co-Chairs:
Kathleen Borgmann, Ph.D., NIDA
Shailesh Kumar, Ph.D., NIAAA
Speakers:
Helene Benveniste, M.D., Ph.D., Yale School of Medicine
Title: Role of glymphatic-lymphatic system in CNS fluid homeostasis and potential dysregulation in Alcohol Use Disorder
Iben Lundgaard, Ph.D., Lund University; Sölvegatan Sweden
Title: The effects of alcohol on CSF flow and the glymphatic system
Stephen Thom M.D., Ph.D., University of Maryland School of Medicine
Title: Morphine-induced elevation of glymphatic flow and inflammatory microparticles in mice
|
| 2:50 pm |
Closing Remarks
|
|
|
|
|
|
|
|
|
